New Jersey S 2060: "Prescription Drug Consumer Transparency Act;" requires pharmacy benefits managers to disclose certain information to benefit plan purchasers and to establish toll-free telephone number for certain inquiries.

Status: Introduced in the Senate, Referred to Senate Commerce Committee (as of 2018-02-26)

State: New Jersey · Session: 218 · Bill: S 2060

Subjects: PHARMACEUTIC

Sponsors: Greenstein, Linda R., Singleton, Troy

View New Jersey S 2060 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.